Abstract
Late-life depressive disorders, late-life bipolar disorders, and late-life psychotic disorders can be debilitating disorders for an older adult who is already struggling with the changes and challenges that come with aging. For some, these are disorders that they have struggled with as a young adult, which continues on into later life; for others, these are disorders that have onset for the first time later in life. The following section provides pertinent information useful in geriatric psychiatry, with questions that address areas of prevalence, characteristics of the disorders, treatment, and the challenges of treatment of these disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013. p. 155–88.
Andrade L, Caraveo-Anduaga JJ, Berglund P, Bijl RV, De Graaf R, Vollebergh W, et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (IPCE) Surveys. Int J Methods Psychiatr Res. 2003;12(1):3–21.
Patten SB, Williams JVA, Lavorato DH, Wang JL, McDonald K, Bulloch AGM. Descriptive epidemiology of major depressive disorder in Canada in 2012. Can J Psychiatr. 2015;60(1):23–30.
Valiengo L, Stella F, Forlenza OV. Mood disorders in the elderly: prevalence, functional impact, and management challenges. Neuropsychiatr Dis Treat. 2016;12:2105–14.
Avari JN, Alexopoulos GS. Models of care for late-life depression of the medically ill: examples from COPD and stroke. Am J Geriatr Psychiatry. 2015;23(5):477–87.
Hegeman JM, de Waal MVM, Comijs HC, Kok RM, van der Mast RC. Depression in later life: a more somatic presentation? J Affect Dis. 2015;170:196–202.
Fountoulakis KN, O’Hara R, Iacovides A, Camilleri CP, Kaprinis S, Kaprinis G, et al. Unipolar late-onset depression: a comprehensive review. Ann Gen Hosp Psychiatry. 2003;2:11.
Dines P, Hu W, Sajatvic M. Depression in later-life: an overview of assessment and management. Psychiatr Danub. 2014;26(1):78–84.
Cheng T. Late-life depression. In: Hategan et al. (eds). Geriatric Psychiatry: A Case-Based Textbook, Springer; 2018, p. 219–35.
Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf PA, Au R. Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology. 2010;75(1):35–41.
Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7(6):323–31.
Canadian Coalition for Seniors Mental Health. National guidelines for senior’s mental health—the assessment and treatment of depression. May 2006. http://ccsmh.ca/wp-content/uploads/2016/03/final-supplement.pdf. Accessed 15 Nov 2017.
McIntosh A. Suicide rates in the elderly. Seniors Matter. http://seniorsmatter.com /suicide-rates-in-the-elderly/. Accessed 15 Nov 2017.
Heisel MJ, Grek A, Moore SL, Jackson F, Vincent G, Malach FM, et al. National guidelines for seniors’ mental health: the assessment of suicide risk and prevention of suicide. Can J Geriatrics. 2006;9(2):S65–71.
Lam RW, McIntosh D, Wang JL, Enns MW, Kolivakis T, Michalak EE, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. Disease burden and principles of care. Can J Psychiatr. 2016;61(9):510–23.
Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU. Second generation antipsychotics in the treatment of major depressive disorder: an update. Chonnam Med J. 2016;52:159–72.
Canadian Medical Association. Determining medical fitness to operate motor vehicles: CMA driver’s guide. 9th ed. Toronto: Joule Inc; 2017.
Hirschfiedl RMA, Bowden CL, Gitlin MJ, Keck PE, Suppes T, Thase ME, et al. Practice guideline for the treatment of patients with bipolar disorder, 2nd ed. American Psychiatric Association; 2010. http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/bipolar.pdf. Accessed 20 Nov 2017.
Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15:1–44.
Kerner N, Prudic J. Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry (London). 2014;4(1):33–54.
Cheng T, Saperson K. Late-life bipolar disorders. In: Hategan et al. (eds). Geriatric Psychiatry: A Case-Based Textbook, Springer; 2018, p. 237–52.
Busko M. “Normal” serum lithium levels might be neurotoxic in geriatric bipolar disorder. Medscape. 2008. https://www.medscape.com/viewarticle/571761. Accessed 20 Nov 2017.
Rise IV, Haro JM, Gjervan B. Clinical features, comorbidity, and cognitive impairment in elderly bipolar patients. Neuropsychiatr Dis Treat. 2016;12:1203–13.
Gildengers AG, Chisholm D, Butters MA, Anderson SJ, Begley A, Holm M, et al. Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression? Psychol Med. 2013;43(4):801–11.
Depp CA, Jeste DV. Bipolar disorder in older adults: a critical review. Bipolar Disord. 2004;6:343–67.
Colijn MA, Bradley HN, Grossberg GT. Psychosis in later life: a review and update. Harv Rev Psych. 2015;23(5):354–67.
Brunelle S, Cole MG, Elie M. Risk factors for late-onset psychoses: a systematic review of cohort studies. Int J Geriatr Psychiatry. 2012;27(3):240–52.
Herrmann N, Lanctôt KL, Hogan DB. Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012. Alzheimers Res Ther. 2013;5(Suppl 1):S5.
Trinh NH, Hoblyn J, Mohanty S, Yaffe K. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease. JAMA. 2003;289(2):210–6. https://doi.org/10.1001/jama.289.2.210.
Patterson TL, Leeuwenkamp OR. Adjunctive psychosocial therapies for the treatment of schizophrenia. Schizophr Res. 2008;100:108–19.
Zimmermann G, Favrod J, Trieu VH. The effect of cognitive behavioural treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis. Schizophr Res. 2005;77:1–9.
Waserman J, Saperson K. Late-life psychosis. In: Hategan A, Bourgeois JA, Hirsch CH, Giroux C, editors. Geriatric psychiatry: a case-based textbook. Springer; 2018, p. 305–18.
Suzuki K, Awata S, Matsuoka H. Short-term effect of ECT in middle-aged and elderly patients with intractable catatonic schizophrenia. J ECT. 2003;19:73–80.
Suzuki K, Awata S, Takano T. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia. Psych Clin Neurosci. 2005;59:481–9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Hategan, A., Bourgeois, J.A., Cheng, T., Young, J. (2018). Late-Life Depressive Disorders, Bipolar Disorders, and Psychotic Disorders. In: Geriatric Psychiatry Study Guide. Springer, Cham. https://doi.org/10.1007/978-3-319-77128-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-77128-1_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-77127-4
Online ISBN: 978-3-319-77128-1
eBook Packages: MedicineMedicine (R0)